XML 34 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Revenue $ 412,977 $ 341,029 $ 262,735
Cost of revenue 343,972 338,166 476,168
Gross profit (loss) 69,005 2,863 (213,433)
Operating expenses:      
Sales and marketing 29,432 31,344 27,292
Research and development 26,070 29,894 26,513
General and administrative 85,167 122,829 293,168
Transaction expenses 2,494 1,668 12,886
Total operating expense 143,163 185,735 359,859
Loss from operations (74,158) (182,872) (573,292)
Interest income (expense), net 1,953 (1,487) (3,331)
Loss on disposal of assets (291) (292) (46)
(Loss) gain on fair value remeasurement of contingent consideration (2,919) 218 (19,405)
Change in fair value of derivative warrant liabilities (534) 10,132 (11,412)
Loss on abandonment of assets (11,226)    
Gain (loss) on foreign currency 3,875 (8,979) 3,032
Total other expense (9,142) (408) (31,162)
Loss before income taxes (83,300) (183,280) (604,454)
Income tax (expense) benefit (5,340) (1,714) 11,701
Gain from equity method investment 3,106 3,358 0
Net loss (85,534) (181,636) (592,753)
Preferred share accretion 0 0 (11,327)
Net loss attributable to common stockholders, basic (85,534) (181,636) (604,080)
Net loss attributable to common stockholders, diluted $ (85,534) $ (181,636) $ (604,080)
Loss per share attributable to common stockholders:      
Basic $ (0.38) $ (0.85) $ (3.79)
Diluted $ (0.38) $ (0.85) $ (3.79)
Weighted average common stock outstanding:      
Basic 225,882,254 213,391,134 159,388,360
Diluted 225,882,254 213,391,134 159,388,360